中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(7): 1457-1459

Current status of the clinical management of non-cirrhotic portal hypertension

DOI: 10.3969/j.issn.1001-5256.2022.07.001

  • Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China

Research funding:

National Science and Technology Major Project (2017ZX10202202)

More Information
  • Corresponding author: XU Xiaoyuan, xiaoyuanxu6@163.com(ORCID: 0000-0002-1759-4330)
  • Received Date: 2022-05-15
  • Accepted Date: 2022-06-16
  • Published Date: 2022-07-20
    Abstract
  • Non-cirrhotic portal hypertension (NCPH) is not uncommon, and its clinical management strategies are different from those for cirrhotic portal hypertension. According to pathogenesis and etiology, NCPH can be classified into prehepatic, hepatic, and posthepatic NCPH, among which hepatic NCPH can be further classified into presinusoidal, sinusoidal, and postsinusoidal NCPH. Timely diagnosis based on clinical manifestation, radiological examination, and pathology and initiation of corresponding treatment are the key to the clinical management of NCPH. However, the diseases in this group are highly heterogeneous and difficult to diagnose, and it is urgent for clinicians to improve their understanding of such diseases, so as to improve the level of clinical management.

     

    • FullText(HTML)
  • loading
    • References(16)
  • [1]
    HE FL, MA L, LI YR, et al. Non-cirrhotic portal hypertension: the highlight of its diagnosis[J]. J Prac Hepatol, 2022, 25(1): 1-4. DOI: 10.3969/j.issn.1672-5069.2022.01.001.

    何福亮, 马琳, 李悦榕, 等. 非肝硬化性门脉高压的临床诊断[J]. 实用肝脏病杂志, 2022, 25(1): 1-4. DOI: 10.3969/j.issn.1672-5069.2022.01.001.
    [2]
    LASAGNI A, CADAMURO M, MORANA G, et al. Fibrocystic liver disease: novel concepts and translational perspectives[J]. Transl Gastroenterol Hepatol, 2021, 6: 26. DOI: 10.21037/tgh-2020-04.
    [3]
    WU X, ZHOU C, LUO SQ. Congenital hepatic fibrosis: clinical features of different clinical types in 75 patients[J]. Chin Hepatol, 2014, 19(7): 479-482, 490. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN201407002.htm

    吴欣, 周超, 罗生强. 先天性肝纤维化不同分型的临床特征——75例分析[J]. 肝脏, 2014, 19(7): 479-482, 490. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN201407002.htm
    [4]
    HULTCRANTZ M, BJÖRKHOLM M, DICKMAN PW, et al. Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study[J]. Ann Intern Med, 2018, 168(5): 317-325. DOI: 10.7326/M17-0028.
    [5]
    GAVRIILIDIS P, MARANGONI G, AHMAD J, et al. State of the art, current perspectives, and controversies of Budd-Chiari syndrome: a review[J]. J Clin Med Res, 2022, 14(4): 147-157. DOI: 10.14740/jocmr4724.
    [6]
    de GOTTARDI A, RAUTOU PE, SCHOUTEN J, et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity[J]. Lancet Gastroenterol Hepatol, 2019, 4(5): 399-411. DOI: 10.1016/S2468-1253(19)30047-0.
    [7]
    de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ - Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
    [8]
    KRISHNA YR, YACHHA SK, SRIVASTAVA A, et al. Quality of life in children managed for extrahepatic portal venous obstruction[J]. J Pediatr Gastroenterol Nutr, 2010, 50(5): 531-536. DOI: 10.1097/MPG.0b013e3181b6a55d.
    [9]
    KHANNA R, SARIN SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction[J]. Hepatol Int, 2018, 12(Suppl 1): 148-167. DOI: 10.1007/s12072-018-9844-3.
    [10]
    AKHAN O, KARAOSMANOGˇLU AD, ERGEN B. Imaging findings in congenital hepatic fibrosis[J]. Eur J Radiol, 2007, 61(1): 18-24. DOI: 10.1016/j.ejrad.2006.11.007.
    [11]
    CANNELLA R, GIAMBELLUCA D, DIAMARCO M, et al. Congenital cystic lesions of the bile ducts: imaging-based diagnosis[J]. Curr Probl Diagn Radiol, 2020, 49(4): 285-293. DOI: 10.1067/j.cpradiol.2019.04.005.
    [12]
    KMEID M, LIU X, BALLENTINE S, et al. Idiopathic non-cirrhotic portal hypertension and porto-sinusoidal vascular disease: review of current data[J]. Gastroenterology Res, 2021, 14(2): 49-65. DOI: 10.14740/gr1376.
    [13]
    ZHAO XY, ZHANG X, WANG TL, et al. Clinical and pathological features of patients with congenital hepatic fibrosis[J]. J Clin Heptaol, 2010, 26(2): 191-193. DOI: 10.3969/j.issn.1001-5256.2010.02.025.

    赵新颜, 张新, 王泰龄, 等. 先天性肝纤维化14例临床病理特点[J]. 临床肝胆病杂志, 2010, 26(2): 191-193. DOI: 10.3969/j.issn.1001-5256.2010.02.025.
    [14]
    Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of pyrrolidine alkaloids-related sinusoidal obstruction syndrome (2017, Nanjing)[J]. J Clin Hepatol, 2017, 33(9): 1627-1637. DOI: 10.3969/j.issn.1001-5256.2017.09.003.

    中华医学会消化病学分会肝胆疾病协作组. 吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年, 南京)[J]. 临床肝胆病杂志, 2017, 33(9): 1627-1637. DOI: 10.3969/j.issn.1001-5256.2017.09.003.
    [15]
    CORBACIOGLU S, TOPALOGLU O, AGGARWAL S. A systematic review and meta-analysis of studies of defibrotide prophylaxis for veno-occlusive disease/sinusoidal obstruction syndrome[J]. Clin Drug Investig, 2022. DOI: 10.1007/s40261-022-01140-y.[Onlineaheadofprint]
    [16]
    Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.

    中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (814) PDF downloads(231) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return